Certara, Inc. (CERT)
Sector: Technology
Industry: Services-Prepackaged Software
Country: United States
Exchange: NASDAQ
Market cap: $1.28B
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Latest financial period: June 30, 2026
Filed with the SEC: August 4, 2026
Estimated earnings date: November 5, 2026
Profit #1267 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 0.5% | 0.6% | 0.7% | 0.9% |
Growth #1332 of 1484 companies
Payout #1117 of 1484 companies
Safety #215 of 1484 companies
Price #981 of 1484 companies
